Kanamycin Ria

FDA 510(k) K772038 · Monitor Science Corp.

Substantially Equivalent

510(k) numberK772038

Submission

Device name
Kanamycin Ria
Applicant
Monitor Science Corp.
Mchenry, IL, US
Received
October 28, 1977
Decision date
January 12, 1978
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
KJI – Radioimmunoassay, Kanamycin
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3520
Specialty
Clinical Toxicology

Other 510(k)s with product code KJI

510(k)DeviceApplicantDecision
K832769Ames Tda Kanamycin Test-Control SerumKJI · Traditional Miles Laboratories, Inc.09/29/1983SE
K823370Advance TM Emit(R) & TM Amikacin AssayKJI · Traditional Syva Co.12/03/1982SE
K823062Kenamycin Fluorescent Immunoassay FiaKJI · Traditional American Diagnostic Corp.11/10/1982SE
K822808TDX KenamycinKJI · Traditional Abbott Laboratories10/08/1982SE
K782125Ria Kit, KanamycinKJI · Traditional Diagnostic Products Corp.01/10/1979SE

More from Diagnostic Products Corp.

510(k)DeviceDecision
K790580Ria Kit, Prostatic AcidJFH · Traditional 05/25/1979SE
K780951Bio-Monitor GentamicinDKD · Traditional 08/14/1978SE
K780950Bio-Monitor TobramycinDID · Traditional 08/14/1978SE
K780949Bio-Monitor AmikacinKLP · Traditional 08/14/1978SE
K772039Beta-Hcg RiaJHI · Traditional 11/23/1977SE

Questions and answers

When was Kanamycin Ria cleared by the FDA?

Kanamycin Ria (K772038) received a 510(k) decision of Substantially Equivalent on January 12, 1978, 76 days after the submission was received.

What is the product code of K772038?

The FDA product code is KJI – Radioimmunoassay, Kanamycin, a Class II (moderate risk) device regulated under 21 CFR 862.3520.